Metastatic Gastrointestinal Stromal Tumor (GIST) Recruiting Phase 2 Trials for Imatinib (DB00619)

Also known as: Metastatic Gastrointestinal Stromal Tumor / Metastatic Gastrointestinal Stromal Tumors (GIST)

IndicationStatusPhase
DBCOND0141952 (Metastatic Gastrointestinal Stromal Tumor (GIST))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05152472A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard TreatmentsTreatment
NCT05009927Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)Treatment